Press Release-Artificial Intelligence in Drug Discovery Market Anticipated to Reach USD 4,197.5 Million by 2028
Vantage Market Research |
Artificial Intelligence in Drug Discovery Market Anticipated to Reach USD 4,197.5 Million by 2028
The Artificial Intelligence in Drug Discovery Market is expected to reach USD 4,197.5 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 41.5% from 2022 to 2028. Factors such as the increasing adoption of cloud-based services & applications, the rising need for controlling the drug development & discovery costs, and an increasing number of cross-industry partnerships & collaborations are expected to accelerate the growth of artificial intelligence in drug discovery market in the coming years.
Key Findings:
The major players involved in the development of Artificial Intelligence in Drug Discovery Market are IBM Corporation (US), Microsoft (US), and Google (US), NVIDIA Corporation (US), Atomwise, Inc. (US), Deep Genomics (Canada), Cloud Pharmaceuticals (US), Insilico Medicine (US), BenevolentAI (UK), Exscientia (UK), Cyclica (Canada), BIOAGE (US), Numerate (US), NuMedii (US), Envisagenics (US), twoXAR (US), OWKIN, Inc. (US), XtalPi (US), Verge Genomics (US), and BERG LLC (US).
Increasing awareness towards the use of AI in the pharmaceutical sector and increasing investment in drug development is concentrating various manufacturers to focus on the development of new pharma products using AI technology. With the help of advanced AI technology, it is possible to move drug screening without doing any extensive experiments. Thus, it increases the high demand for AI in the drug discovery market in the past few years. In addition, AI is changing drug discovery by providing various detection parameters such as target selection & validation, compound screening & lead optimization, offered preclinical studies, and clinical trials for recognizing diseases of patients. All these parameters are propelling the growth of artificial intelligence in the drug discovery market in the coming years.
The innovations and advancements in artificial intelligence like deep learning and machine learning have enabled pharmaceutical companies to identify the molecule binding property of the drug with high precision, this, fuels the growth of artificial intelligence in the drug discovery market. There are several options to carry out the standard processes like customization capability of artificial intelligence platforms and data mining. This happens because of the availability of new technological advancement in AI; therefore, it helps in fuelling the AI in drugs discovery market growth.
Add banner
Access Full Report
Cosmetic Ingredients Market - Global Industry Assessment (2022 - 2028)
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Healthcare
Veterinary Care Market Size, Share & Trends Analysis Report.
13 Nov 2023
10 Min Read
Healthcare
Surgical Imaging Market Size, Share & Trends Analysis Report.
13 Nov 2023
10 Min Read
Healthcare
Surgical Imaging Market Size, Share & Trends Analysis Report.
13 Nov 2023
10 Min Read
Latest Blogs
13 Nov 2023
Veterinary Care Market Size, Share & Trends Analysis Report.
Healthcare
13 Nov 2023
Surgical Imaging Market Size, Share & Trends Analysis Report.
Healthcare
13 Nov 2023
Surgical Imaging Market Size, Share & Trends Analysis Report.
Healthcare
Contact
Toll Free Number+1 (877) 462-2282